- Hepatitis research and development timeline
- Hepatitis C Virus patent assignments: patents with HCV in the patent claim
- KEI Policy Brief: Non-Voluntary use of HCV patents in the United States
- SCCR28: Chair’s Conclusions (No recommendations on broadcasting or limitations and exceptions for libraries and archives)
- Gilead in 2013: AbbVie sought to eliminate competition and dominate market for HCV drugs
- KEI asks FTC to investigate Shire decision to abandon efforts to compete in US market for Fabry’s disease treatments
- New UK Parliamentary report on Global TB urges the United Kingdom to explore a WTO Agreement on the Provision of Public Goods
- US Court issues compulsory license for know-how protected as trade secret
- Senators Wyden and Grassley launch investigation of pricing of Sovaldi, treatment for Hepatitis C Virus
- 28 October 2014: WTO Innovation Fair on the margins of WTO TRIPS Council review of the Paragraph 6 system
The European Generics Association has written to the European Parliament asking that patents be removed from the Anti-Counterfeiting Agreement. A PDF copy of their letter is here. The text in html follows:
MEP Mr. Gianluca Susta
1049 Bruxelles- Belgium
Brussels, 5th of November 2010
Ref. EGA comments to the consolidated text on ACTA that reflects changes made during the
September 2010 Tokyo round1.
Dear Mr. Susta,
The following statement is the oral intervention made by USTR at the WTO Council for TRIPS (October 2010) regarding ACTA.
Talking Points of the United States for TRIPS Council Meeting of October 26, 2010
Agenda Item P
We would like to thank other delegations for their interest in the Anti-Counterfeiting Trade Agreement (ACTA).
Delegations will recall that the United States and other delegations have been interested in discussing the issue of IP enforcement at this Council for many years and so we’re pleased to have another discussion today.
The following statement was delivered by USTR at the WTO Council for TRIPS Annual Review of the Paragraph 6 System on Wednesday, 27 October 2010.
Agenda item F, Annual Review of the Paragraph 6 System
We are pleased to be here today to participate in the annual review on the implementation of paragraph 6 of the Doha Declaration.
On November 2, 2010, U.S. Senator Bernard Sanders (VT-I) sent a letter to Margaret Hamburg, the FDA Commissioner, urging the agency to review the ethical implications of the 12 years of marketing exclusivity created by the Biologics Price Competition and Innovation Act of 2009 (BPCI Act).
Remarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilitiesSubmitted by thiru on 2. November 2010 - 11:50
The following statement was delivered on Wednesday, 27 October 2010 by the UNAIDS Secretariat and on behalf of UNDP during the Annual Review of Paragraph 6.
World Trade Organization
Council for TRIPS – Regular Session
Annual Review of Paragraph 6
Doha Declaration on the TRIPS Agreement and Public Health
Agenda item 4 – Capacity building on the Paragraph 6 System and related TRIPS flexibilities
Remarks by UNAIDS Secretariat and on behalf of UNDP
27 October 2010
Mr Chair, Distinguished Delegates
On Wednesday, 27 October 2010, Brazil delivered the following intervention during the annual review of the Paragraph 6 system at the WTO TRIPS Council. The Brazilian intervention followed Canada's detailed explanation of her use of the Paragraph 6 system in the Apotex/Rwanda case. The Brazilian intervention voiced concern over the future prospects of access to competitively priced second and third line ARVs raising questions as to whether the Paragraph 6 system would be economically viable for generic producers.
The following is extracted from China's intervention made at the WTO TRIPS Council meeting held from 26-27 October 2010; this reflects China's position on ACTA.
On Wednesday, 27 October 2010, Canada delivered the three interventions to the WTO TRIPS Council related to the review of the Paragraph 6 system. The first intervention below details the Canadian experience using the Paragraph 6 system in the case of Apotex and Rwanda.
CANADA Intervention: (1) Experience using the System (Apotex-Rwanda Case)
As we recall, the 2003 WTO Decision on TRIPS and Public Health was an intensely negotiated decision that garnered unanimous support from all WTO Members.
The following statement was delivered by Brazil at this week's TRIPS Council.
TRIPS Enforcement Trends/ACTA – TRIPS Council – Intervention by Brazil
According to press releases circulated in the first week of this month, the negotiating process of ACTA is virtually concluded.
A few points only would still remain open and those points would not prevent a final agreement from being reached soon, according to statements released by authorities from the countries participating in the ACTA negotiations.
On Wednesday, 27 October 2010, the WTO TRIPS Council held its annual review of the Paragraph 6 System. IP-Watch has a link to the detailed program of the annual review. This annual review of the Paragraph 6 system lasted till around 8 PM Geneva time. More details of this closed door meeting will be provided in due course.
Use of Article 1.1 of the TRIPS in the US/China WTO dispute over the enforcement of intellectual property rights
USTR claims that Article 1.2.1 of ACTA provides the flexibility to overlook inconsistencies between US law and ACTA. Below is the text from both Article 1.2.1 of ACTA, and Article 1.1 of TRIPS:
ACTA ARTICLE 1.2: NATURE AND SCOPE OF OBLIGATIONS
Michèle Rivasi, a Member of the European Parliament, representing South East France for The Greens, has asked the European Commission: "Given the possible impacts of the inclusion of patents the agreement on access to medicines and on innovation, would the Commission consider accepting the exclusion of patents from the agreement as proposed by a number of ACTA negotiating parties?" The full text of her question follows:
Françoise Castex, French Socialist MEP, asks about USTR assertions that ACTA does not require changes in US lawSubmitted by James Love on 25. October 2010 - 12:50
(A PDF version of this is available here.)
Knowledge Ecology International
October 25, 2010
Letter to the European Parliament regarding ACTA
- September 24 to October 3, 2007, WIPO General Assembly meets and approves the WIPO Development Agenda.
- October 23, 2007. Joint announcement is made regarding the formal launch of negotiations on ACTA. The USTR announcement is here.